ONC.TO - Oncolytics Biotech Inc.

Toronto - Toronto Real Time Price. Currency in CAD
Currency in CAD

Valuation Measures4

Market Cap (intraday) 135.07M
Enterprise Value 103.31M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)5.10
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -3.83

Trading Information

Stock Price History

Beta (5Y Monthly) 1.79
52-Week Change 359.46%
S&P500 52-Week Change 31.77%
52 Week High 33.1000
52 Week Low 31.0600
50-Day Moving Average 31.8844
200-Day Moving Average 32.0010

Share Statistics

Avg Vol (3 month) 357.62k
Avg Vol (10 day) 3100.31k
Shares Outstanding 564.09M
Implied Shares Outstanding 6N/A
Float 863.06M
% Held by Insiders 11.34%
% Held by Institutions 11.47%
Shares Short (May 14, 2023) 448.2k
Short Ratio (May 14, 2023) 40.91
Short % of Float (May 14, 2023) 40.08%
Short % of Shares Outstanding (May 14, 2023) 40.08%
Shares Short (prior month Apr 13, 2023) 461.71k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 24, 2018
Ex-Dividend Date 4N/A
Last Split Factor 2105:1000
Last Split Date 3May 24, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-42.85%
Return on Equity (ttm)-80.61%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -27.26M
Net Income Avi to Common (ttm)-24.49M
Diluted EPS (ttm)-0.3300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)29.67M
Total Cash Per Share (mrq)0.46
Total Debt (mrq)567k
Total Debt/Equity (mrq)2.20
Current Ratio (mrq)13.88
Book Value Per Share (mrq)0.40

Cash Flow Statement

Operating Cash Flow (ttm)-24.93M
Levered Free Cash Flow (ttm)-15.04M